Importer of Controlled Substances; Notice of Application, 69705 [2010-28532]

Download as PDF Federal Register / Vol. 75, No. 219 / Monday, November 15, 2010 / Notices a check in that amount to the Consent Decree Library at the stated address. Maureen Katz, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 2010–28599 Filed 11–12–10; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on May 14, 2010, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule II: Drug Schedule srobinson on DSKHWCL6B1PROD with NOTICES Methamphetamine (1105) ............ Phenylacetone (8501) .................. Raw Opium (9600) ....................... Concentrate of Poppy Straw (9670). 18:04 Nov 12, 2010 Jkt 223001 Dated: November 1, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–28532 Filed 11–12–10; 8:45 am] II II II II BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE The company plans to import the listed controlled substances to manufacture bulk controlled substances for sale to its customers. No comments, objections, or requests for any hearings will be accepted on any application for registration or reregistration to import crude opium, poppy straw, concentrate of poppy straw, and coca leaves. As explained in the Correction to Notice of Application pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for hearings on applications to import narcotic raw material are not appropriate. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedule I or II, which fall under the authority of section 1002(a)(2)(B) of the Act [(21 U.S.C. 952(a)(2)(B)] may, in the circumstances set forth in 21 U.S.C. 958(i), file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement VerDate Mar<15>2010 Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than December 15, 2010. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Marine Well Containment Venture Notice is hereby given that, on September 29, 2010, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Marine Well Containment Venture (‘‘MWCV’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, new entities are now participating in the MWCV. Pursuant to Section 6(b) of the Act, the identities of the new entities participating in the venture are: Chevron Gulf of Mexico Response Co. LLC, Houston, TX; ConocoPhillips Marine Containment Holdings Co. LLC, Houston, TX; ExxonMobil Offshore Well Containment LLC, Houston, TX; and Shell Offshore Response Co. LLC, Houston, TX. No other changes have been made in either the membership or planned PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 69705 activity of the venture. The composition of members in this venture may change, and MWCV intends to file additional written notifications disclosing all changes in membership. On August 18, 2010, MWCV filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on October 12, 2010 (75 FR 62570). Patricia A. Brink, Deputy Director of Operations Antitrust Division. [FR Doc. 2010–28558 Filed 11–12–10; 8:45 am] BILLING CODE 4410–11–M NATIONAL CREDIT UNION ADMINISTRATION Sunshine Act Notice 10 a.m., Wednesday, November 17, 2010. PLACE: Board Room, 7th Floor, Room 7047, 1775 Duke Street, Alexandria, VA 22314–3428. STATUS: Closed. TIME AND DATE: Matters To Be Considered 1. Pilot Programs (3). Closed pursuant to some or all of the following: Exemptions (4) and (8). 2. Insurance Appeals (3). Closed pursuant to some or all of the following: Exemptions (4) and (6). 3. Personnel (2). Closed pursuant to some or all of the following: Exemption (2). 4. Consideration of Supervisory Activities (4). Closed pursuant to some or all of the following: Exemptions (8), (9)(A)(ii) and 9(B). FOR FURTHER INFORMATION CONTACT: Mary Rupp, Secretary of the Board, Telephone: 703–518–6304. Mary Rupp, Board Secretary. [FR Doc. 2010–28795 Filed 11–10–10; 4:15 pm] BILLING CODE P NATIONAL CREDIT UNION ADMINISTRATION Sunshine Act; Notice of Agency Meeting 9 a.m., Thursday, November 18, 2010. PLACE: Board Room, 7th Floor, Room 7047, 1775 Duke Street, Alexandria, VA 22314–3428. STATUS: Open. MATTERS TO BE CONSIDERED: 1. Interim Final Rule—Part 704 of NCUA’s Rules and Regulations, TIME AND DATE: E:\FR\FM\15NON1.SGM 15NON1

Agencies

[Federal Register Volume 75, Number 219 (Monday, November 15, 2010)]
[Notices]
[Page 69705]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28532]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this 
is notice that on May 14, 2010, Chattem Chemicals, Inc., 3801 St. Elmo 
Avenue, Building 18, Chattanooga, Tennessee 37409, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as an importer of the basic classes of controlled substances listed in 
schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methamphetamine (1105).....................  II
Phenylacetone (8501).......................  II
Raw Opium (9600)...........................  II
Concentrate of Poppy Straw (9670)..........  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances to 
manufacture bulk controlled substances for sale to its customers.
    No comments, objections, or requests for any hearings will be 
accepted on any application for registration or re-registration to 
import crude opium, poppy straw, concentrate of poppy straw, and coca 
leaves. As explained in the Correction to Notice of Application 
pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and 
requests for hearings on applications to import narcotic raw material 
are not appropriate.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances listed in schedule I or II, which fall under the authority 
of section 1002(a)(2)(B) of the Act [(21 U.S.C. 952(a)(2)(B)] may, in 
the circumstances set forth in 21 U.S.C. 958(i), file comments or 
objections to the issuance of the proposed registration and may, at the 
same time, file a written request for a hearing on such application 
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 
1316.47.
    Any such comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than December 15, 2010.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, (40 FR 43745-46), all 
applicants for registration to import a basic class of any controlled 
substance in schedule I or II are, and will continue to be, required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-28532 Filed 11-12-10; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.